Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 3, 2001, Pages 660-665

  Sim, Sang ^a   Rosenzweig, Kenneth E ^a   Schindelheim, Rachel ^a   Ng, Kenneth K ^a   Leibel, Steven A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Lung cancer; Non small cell lung cancer; Radiotherapy; Three dimensional conformal radiation therapy

Indexed keywords

PATIENT TREATMENT; PLANNING; RADIATION; RADIOGRAPHY; TOXICITY;

LUNG CANCER;

CHEMOTHERAPY;

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; MITOMYCIN C; PACLITAXEL; PLATINUM; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL TIME; THORACOTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0035501216     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01666-2     Document Type: Article

References (23)

1. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial
2. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
3. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
4. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients
5. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
6. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group
7. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
8. Dose escalation for non-small cell lung cancer using conformal radiation therapy
9. Results of multifield conformal radiation therapy of non-small-cell lung carcinoma using multileaf collimation beams
10. Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III non-small-cell lung cancer
11. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: Preliminary report of a phase I trial
12. Dose computations for three-dimensional radiation treatment planning
13. A comprehensive three-dimensional radiation treatment planning system
14. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations
15. Fitting of normal tissue tolerance data to an analytic function
16. Nonparametric estimation from incomplete observations
17. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small cell lung cancer: A meta-analysis
18. Role of radiotherapy in combined modality treatment of locally advanced non-small cell-lung cancer
19. Final report of the 70.2 and 75.6 Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer
20. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
21. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410
22. The generation of intensity-modulated fields for conformal radiotherapy by dynamic collimation
23. Generation of arbitrary intensity profiles by dynamic jaws or multileaf collimators